A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis

Summary

The objective of this study was to evaluate the safety and efficacy of multiple doses of LNK01001 monotherapy versus placebo in the treatment of adults with active Ankylosing Spondylitis

Timeline

Start

2022-01-06

Primary completion

2022-12-06

Completion

2023-06-20

Outcome

Met primary endpoint

release “with efficacies exceeding all projected primary and critical secondary endpoints” simcere.com ↗

Drugs

Indications